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ABSTRACT
Introduction Recognition that child maltreatment (CM) 
and domestic violence and abuse (DVA) are common and 
have serious and long- term adverse health consequences 
has resulted in policies and programmes to ensure that 
services respond to and safeguard children and their 
families. However, high- quality evidence about how 
services can effectively intervene is scant. The value of 
the current evidence base is limited partly because of 
the variety of outcomes and measures used in evaluative 
studies. One way of addressing this limitation is to develop 
a core outcome set (COS) which is measured and reported 
as a minimum standard in the context of trials and other 
types of evaluative research. The study described in this 
protocol aims to develop two discrete COSs for use in 
future evaluation of psychosocial interventions aimed at 
improving outcomes for children and families at risk or 
with experience of (1) CM or (2) DVA.
Methods and analysis A two- phase mixed methods 
design: (1) rapid reviews of evidence, stakeholder 
workshops and semistructured interviews with adult 
survivors of CM/DVA and parents of children who have 
experienced CM/DVA and (2) a three panel adapted E- 
Delphi Study and consensus meeting. This study protocol 
adheres to reporting guidance for COS protocols and 
has been registered on the Core Outcome Measures for 
Effectiveness Trials (COMET) database.
Ethics and dissemination We will disseminate our 
findings through peer- reviewed and open access 
publications, the COMET website and presentations at 
international conferences. We will engage with research 
networks, journal editors and funding agencies to promote 
awareness of the CM- COS and DVA- COS. We will work 
with advisory and survivor and public involvement groups 
to coproduce a range of survivor, policy and practice facing 
outputs.
Approval for this study has been granted by the Research 
Ethics Committee at University College London.
INTRODUCTION
Widespread recognition that child maltreat-
ment (CM) and domestic violence and abuse 
(DVA) are common and have serious and 
long- term adverse health consequences1 2 
has resulted in policies and programmes to 
ensure that services respond to and safeguard 
children (and their families) at high risk of 
or with experience of CM and/or DVA.3–6 
However, high- quality evidence about how 
services can effectively intervene is scant.7–9
The value of the current evidence base 
is limited partly because of the variety of 
outcomes and measures used in evaluative 
studies.7 8 This hampers the ability to aggre-
gate evidence pertaining to one particular 
type of intervention, so as to build a compre-
hensive picture of its effectiveness when deliv-
ered to different populations or in different 
contexts. Similarly, it is challenging to make 
comparisons between different types of inter-
ventions, which purport to address the same 
problem within the same group of individ-
uals.10 11
Strengths and limitations of this study
 ► To our knowledge this is the first attempt to develop 
core outcome sets to address family violence and 
abuse.
 ► The study draws on diverse evidence sources and 
includes people with lived experience, practitioners 
and policy- makers, as well as researchers.
 ► This study provides the opportunity to consider the 
overlap in outcomes sought across two different but 
related exposures.
 ► This study is limited by the lack of direct involve-
ment of children and young people.
 ► It is beyond the means of the study to involve sur-
vivors and service providers from low- income and 
middle- income countries (LMICs), although we will 
include research from LMICs in the evidence re-
views and actively recruit researchers from or re-
searching LMIC settings.
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More fundamentally, outcomes measured in CM and 
DVA intervention studies are often a poor or partial 
reflection of the concepts of success held by those who 
use, deliver and pay for interventions.7 8 12 The ultimate 
goal of intervention studies is to identify interventions 
that can benefit individuals, families and communities 
in the future. Therefore, it is crucial that they measure 
outcomes reflecting the priorities and expectations of 
these groups so the evidence they generate is relevant 
to consumers. Outcomes also need to resonate with 
the priorities of policy- makers and service providers, 
else effective interventions may be overlooked by those 
responsible for funding and/or delivery decisions and 
never commissioned or implemented.13 14
Together, these issues mean it is difficult to extract the 
information needed to inform real- world decisions about 
which CM/DVA interventions to commission and scale 
and which to stop funding.
One way of addressing the limitations set out above 
is to develop a core outcome set (COS), a standardised 
set of outcomes that researchers, providers, service 
users and commissioners consider critical or important 
outcomes in the management of a condition or in this 
case, a complex public health challenge.11 15 The COS is 
then measured and reported, as a minimum standard in 
the context of trials or other types of research and eval-
uation15 and sometimes practice- based monitoring.16 
The aim is to enhance the methodological standard and 
utility of research in the field, by increasing consistency 
and reducing reporting bias (where many outcomes are 
measured and only favourable effects reported) and 
ensuring the views of important constituencies influence 
the selection of outcomes to be included in the COS.10
The idea of the COS as a mechanism for improving 
evidence quality has gathered momentum over the past 
decade since the establishment of the Core Outcome 
Measures for Effectiveness Trials (COMET) initiative in 
2010 ( www. comet- initiative. org).15 While the number 
of COSs being developed has increased steadily,16 17 it 
is clear that studies have mostly focused on COS devel-
opment for specific health conditions, pharmacological 
or surgical interventions and/or discrete interventions 
delivered in healthcare settings.16 17 In contrast, there has 
been relatively less focus on the development of COSs in 
relation to public health problems that require complex 
multisectoral responses, often delivered to whole families 
or multiple members of the same family.
Current study
The study sets out to develop two discrete COSs for use 
in future evaluation of psychosocial interventions, which 
aim to improve outcomes for children and families at risk 
of or with experience of CM or DVA. We use the term 
‘at risk’ so as not to limit the scope of this work to those 
interventions delivered to families following substanti-
ated experience of CM or DVA or where children and 
families define their experiences as such but to include 
interventions offered to families where it is suspected that 
an exposure may have taken place or where children’s 
experiences are thought to be on a trajectory towards this.
Children’s experiences of CM and DVA frequently 
overlap18 and experience of DVA is often conceived of as 
a type of maltreatment in its own right or a feature of 
emotional maltreatment.19 20 Nevertheless, the conceptu-
alisation and response to these two types of trauma can 
be different, despite similar consequences. For example, 
there is variation as to whether exposure to DVA is consid-
ered as a form of CM. Where DVA is considered as a form 
of CM, evidence suggests there may be different levels of 
state intervention where the primary concern is exposure 
to DVA versus experience of CM.19 20 This provides the 
rationale for developing separate outcome sets, however 
we will explore where the derived outcome sets overlap 
with a view to identifying outcomes that can be measured 
in family contexts where both CM and DVA occur. This 
is a move away from a focus on single- problem areas 
towards recognition of the constellation of risks often 
experienced by children and their families.
METHODS AND ANALYSIS
This study protocol adheres to reporting guidance for 
COS protocols21 and has been registered on the COMET 
database.
Scope of outcome sets
The CM- COS and the DVA- COS will be developed to 
support evaluation of the impact of targeted child and/
or family focused psychosocial interventions or services, 
in the context of both research (randomised and non- 
randomised studies) and practice (service evaluations 
and monitoring).
The target population for interventions is children 
aged less than 19 years of age with experience of (current 
or previous) DVA or CM. Given that many interventions 
aiming to improve child outcomes do so via support deliv-
ered to parents or multiple family members (rather than 
directly to the child),7 8 22 the target group also includes 
parents or families of children experiencing CM or DVA.
We use a definition of psychosocial interventions set 
out by the Institute of Medicine.23
Interventions within the scope of this study include 
psychotherapies (eg, cognitive- behavioural therapy), 
community- based treatments, family/systemic therapy, 
vocational rehabilitation, peer support services, integrated 
care interventions and out- of- home care (ie, foster care or 
adoption). Interventions may be delivered in one or more 
contexts (eg, clinic, school, community). Interventions 
may be individual, dyad or group based or a combination 
and delivered to children with or without their parents, 
to parents alone, to family groups or some combination. 
To be in scope, an intervention must implicitly or explic-
itly aim to improve child outcomes by one or more of 
the following mechanisms: (1) reducing the risk of CM/
DVA occurring/reoccurring in the family; (2) improving 
parental (non- harming and/or harming) functioning 
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as an indirect route to improving child outcomes; (3) 
limiting or preventing poor mental health, reduced well- 
being or function in children following exposure and (4) 
promoting children’s recovery following experience of 
CM or DVA—here, we relate to the recovery model defi-
nition which emphasises perceptions of resilience, self- 
identity, a sense of empowerment, hope and optimism 
(eg, Leamy et al24). Universal and targeted structural 
interventions are not in scope.
Study design
The study is being undertaken in two stages (see figure 1). 
The first stage is underway and seeks to identify candi-
date outcome areas, domains and indicators. Multiple 
methods are being used to identify items for the candi-
date list including rapid evidence reviews, consultation 
with key stakeholders and qualitative interviews. Data will 
be synthesised to produce a taxonomy of outcomes, from 
which the two candidate lists of indicators (structured by 
area and domain) will be produced.
The second stage, which began in April 2021, will 
incorporate an adapted two- round E- Delphi Study and 
consensus meeting, with the aim of building agree-
ment between different stakeholder groups regarding 
important outcomes. The E- Delphi technique is an itera-
tive, multistage, online process designed to seek opinion 
from and develop consensus among a defined group of 
individuals (panel). The method is frequently used when 
evidence in an area is known to be limited or contradic-
tory and is widely used in health and social care research. 
Key features include (1) an anonymous survey process, 
whereby a panel (or multiple panels) of experts (by 
profession and/or experience) use a questionnaire to 
rate a series of statements over a number of rounds; (2) 
the provision of structured feedback to panel members 
between rounds with the ability to adjust ratings in light 
of knowledge about the group opinion and (3) anonymity 
for panel members during the process.25 These features 
can facilitate the convergence of opinion across rounds, 
helping to build consensus while at the same time high-
lighting areas of continuing disagreement. This method 
has been used extensively in the context of core outcomes 
research.16 26 27
Figure 1 Study design. CM, child maltreatment; COS, core outcome set; DVA, domestic violence and abuse.
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We will recruit three panels for participation in the 
E- Delphi Study to ensure that each stakeholder group is 
equally represented in the final consensus.28 In a further 
effort to ensure that the views of those with lived expe-
rience remain a central focus during this exercise, the 
E- Delphi method will be adapted so that in addition to 
feedback about their individual and own panel scores for 
each item, professional and researcher panels will also 
receive feedback about the scores of the lived experience 
panel. This adaptation is informed by evidence that feed-
back of patient scores to clinicians results in an expanded 
set of consensus items that better reflect the priorities of 
patients.29 Additional feedback will not be given to the 
lived experience panel, so as to minimise the possibility 
of perceived power differentials influencing this panel’s 
ratings.28 A final face- to- face consensus meeting will be 
used to review and verify findings from the E- Delphi 
Study, clarify any remaining uncertainty and ratify the 
final COS.
Study oversight
A steering committee including practitioners, policy- 
makers and researchers representing CM and DVA fields 
has been formed and will meet formally two times per 
year.
Patient and public involvement
Three public advisory groups are also overseeing and 
consulting on the study. One group is comprised of indi-
viduals with lived experience of DVA and one of care expe-
rienced young people. These groups have been formed 
in partnership with relevant survivor- led organisations. 
A third group is comprised of young people affiliated to 
the National Children’s Bureau who are consulting more 
broadly on the work of the Children and Families Policy 
Research Unit. Partner organisations are funded to orga-
nise three meetings per year and to provide appropriate 
remuneration to participants. Additional funds will be 
paid to cover scheduled review activities organised with 
partner agencies via email. Members of advisory groups 
will be involved in all aspects of the study including the 
development of the outcomes taxonomy, development of 
the list of candidate indicators, preparation of materials 
for the E- Delphi and dissemination of results.
Participants
Workshops (phase I): We will invite 30–40 individuals to 
attend each workshop, the aim of which will be to discuss 
definitions of CM/DVA and outcomes perceived to be 
important for survivors. Relevant researchers (mainly UK) 
and professionals from each field (eg, support workers, 
primary and secondary health practitioners, education 
staff, local authority commissioners, local and national 
policy- makers) will be identified from the research team’s 
networks, authorship of key publications and internet 
searches.
People with lived experience of CM/DVA will be 
approached via gatekeeper organisations and existing 
survivor/researcher networks known to the research 
team. Concerted effort will be made to invite individ-
uals representing groups known to be marginalised from 
services or research on DVA/CM or who receive inade-
quate service responses owing to discrimination or lack 
of service differentiation (ie, assuming all groups require 
the same response).30–33
Semistructured interviews (phase I): We will recruit a 
sample of approximately five adults who are identified as 
survivors of CM or exposure to DVA during childhood 
and five parents of children currently aged 0–18 years 
with lived experience of DVA/CM. In the first instance, 
we will seek to recruit participants via gatekeeper organ-
isations (see Procedure section below), although if 
recruitment is insufficient, we will seek approval for direct 
recruitment via social and print media. To take part in 
interviews, participants will be required to self- identify as 
having experienced CM/DVA or as having a child who 
has experienced CM/DVA.
Adapted international E- Delphi Study (phase II): 
Three separate panels will be recruited to take part in 
the consensus study comprising: (1) individuals with 
lived experience (parents of children with experience of 
CM/DVA and adults experiencing abuse in childhood); 
(2) frontline and strategic professionals involved in the 
delivery and commissioning of CM/DVA services and 
related policy and (3) researchers. The first two panels 
will include members from the UK, with the researcher 
panel including international researchers from high- 
income, middle- income and low- income countries. We 
will aim to recruit 30 individuals to each panel.
Survivors and professionals taking part in the workshops 
and semistructured interviews described above (and who 
give consent for further contact) will be approached for 
participation in the lived experience and professional 
panels, respectively. If needed, additional participants 
will be recruited through key organisations working with 
either CM or DVA survivors and snowball sampling. Key 
researchers, with at least one peer- reviewed publication 
from either the CM field or DVA field, will be identified 
through the rapid reviews, researcher networks, participa-
tion in workshops and via the expert panel. For all panels, 
participants must be able to read and understand English 
in order to participate.
Consensus workshop following E- Delphi Study (phase 
II): A face- to- face consensus meeting, with a purposively 
sampled panel (n=30) representing all key stakeholder 
groups, will be recruited from participants taking part 
in earlier phases of the study. Individuals outside of the 
study will be approached as needed to ensure balanced 
representation and inclusion of individuals of strategic 
importance to take up and implementation of study find-
ings. Appropriate amendments to ethical approvals will 
be sought to accommodate this.
It is important to note that although the focus of this 
work is on child- targeted and family- targeted interven-
tions, this study does not directly involve children and 
young people aged <18 years with experience of CM 
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and/or DVA. We initially explored this possibility with 
third sector organisations and professionals and clini-
cians comprising our expert advisory group. However, it 
was concluded that the nature of this research was not 
sufficient to justify the potential harm and safeguarding 
issues that may have been raised by approaching children 
and young people with recent experience of violence 
and abuse, particularly as they may not be engaged 
with supportive services. Instead, the voices of children 
and young people have been included indirectly via (1) 
inclusion of outcomes extracted from qualitative studies 
reporting children and young people’s experiences, (2) 
recruitment of adult survivors of CM and childhood 
exposure to DVA as well as parents of children with recent 
experience and (3) consultation with care experienced 
young people who are advising on the conduct of the 
study, including review of outcomes identified in the first 
phase of this work. Nevertheless, the lack of children and 
young people’s direct participation is a limitation to this 





We will conduct a series of rapid reviews using systematic 
methods (see online supplemental appendices for proto-
cols and review questions). We will review experimental 
and quasi- experimental intervention studies (interna-
tional), qualitative studies containing primary accounts of 
experience of relevant interventions or outcomes that are 
sought by families and children experiencing CM/DVA 
(international) and the grey (UK) literature reporting 
descriptions of interventions, service evaluations or 
consultation regarding appropriate outcomes across the 
DVA and CM fields.
We will search a range of relevant databases and websites 
under the guidance of an expert librarian. Following 
rapid review techniques,34 35 we will search since 2014 
for intervention studies (covering the time elapsed since 
previous key reviews, Macdonald et al and Howarth et 
al8 36) and 2005–2014 for the qualitative studies to build 
on recent qualitative reviews.37 The grey literature review 
will primarily focus on searches of relevant UK organisa-
tion websites and will include any service or intervention 
evaluation or any consultation or review, to identify rele-
vant candidate outcomes or outcome tools for use in the 
context of service delivery or evaluation.
A second reviewer will screen and extract data from a 
minimum of 5% of titles/abstracts and articles to ensure 
consistency. Inter- rater reliability kappa scores will be 
calculated and disagreements will be resolved through 
discussion (or a third reviewer if necessary) throughout 
the process. Relevant outcome indicators will be extracted, 
as well as their measurement instruments where possible. 
There will be no appraisal of study quality and outcomes 
will be extracted from all identified papers.
Stakeholder workshops
We will hold two invite- only workshops (one focused 
on CM and one focused on DVA) to gather stakeholder 
views. The purpose of these events will be to (1) explore 
definitional issues, specifically how each phenomenon is 
defined by particular groups and the function that this 
definition plays in practice (in terms of enabling access 
to services/interventions and measuring change) and (2) 
explore outcomes perceived to be important indicators 
of benefit or harm for children and families experiencing 
CM/DVA.
Participants will be seated on tables of 6–8. Each table 
will include at least two individuals with lived experience 
and one facilitator. Guided by facilitators, participants will 
be asked to generate ideas relating to desirable (or unde-
sirable) outcomes, unconstrained by what they believe to 
be measurable or achieved via currently available inter-
ventions. This will be an attempt to ensure output is not 
merely reflective of current practice or discourse. Desig-
nated scribes will take notes throughout the day, which 
will be collated and analysed thematically.38 Participants 
in the workshops will be asked for permission to contact 
them at a later date for the purpose of inviting them to 
participate in the international E- Delphi Study.
Interviews with individuals with lived experience of DVA/CM as a 
child or as parent of a child
Participants will be identified via key gatekeeper organ-
isations (where work with survivors of CM/DVA is core 
business) contacted for the purpose of workshop partic-
ipation (see above). Participants will be approached 
directly by a professional from the gatekeeper organi-
sation or they will receive an open invitation circulated 
through the organisation’s survivor network. Where 
participants are approached by professionals, they will 
be given brief information about the study and asked for 
permission to pass contact details to the research team. 
Individuals responding to an open invitation will be asked 
to contact a member of the research team directly. They 
will be assured of the anonymity of their involvement.
Basic sociodemographic information and minimal 
information about experiences of CM or DVA will be 
collected via questionnaire prior to the interview and will 
be used for sample description. Participants will have the 
opportunity to take part in the interview face to face, by 
video call or by phone, according to their personal prefer-
ences and public health guidance on social distancing. For 
those participants who wish to take part but are unable to 
speak directly to interviewers, they will be able to answer 
the interview questions by email.39 Interview schedules 
will be used to guide interviews, which will be recorded 
and transcribed verbatim and analysed thematically.38
Outcome generation
A list of candidate outcome areas (eg, health and well- 
being), domains (eg, mental health) and specific indica-
tors (eg, withdrawal from friends and activities) will be 
generated iteratively by the research team, drawing on 
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all information sources described above. An unedited 
candidate list of outcome indicators generated from 
stakeholder workshops will be used as a starting point. 
Identification of duplicate and overlapping outcome indi-
cators from the list will be undertaken in parallel by two 
team members (CP, EH). Similar items will be dropped 
or combined to produce a reduced inventory. Disagree-
ments between team members will be resolved through 
discussion. All suggestions to drop or combine items will 
be reviewed by two further research team members (RG, 
GF) and survivor involvement groups. Similar indicators 
(ie, outcomes that could be compared across studies 
or combined in a meta- analysis21) will be grouped into 
outcome domains by two team members and reviewed by 
two further members of the research team and survivor 
involvement groups. Simultaneously, a taxonomy to 
organise domains into broader outcome areas will be 
developed. Here, we will draw on existing practical and 
theoretical frameworks to categorise health outcomes,40 
as well as the aetiology and impacts of DVA and CM.41–44 
This overarching framework to describe the hierarchical 
structure of outcomes identified in workshops will be 
reviewed and refined by all members of the research 
team, the expert advisory group and survivor involvement 
groups.
A candidate list of outcome indicators from the rapid 
reviews will be generated and deduplicated (CP, EH). 
Four research team members and at least two survivor 
representatives will, in parallel, attempt to categorise indi-
cators using the developed taxonomy. Categorisations will 
be compared, disagreements discussed and consensus 
reached through discussion. New domains or areas will be 
added where necessary. Unique indicators (not already 
included) will be identified from the candidate list gener-
ated from the reviews and added to the taxonomy. This 
iterative process will be repeated with data yielded from 
interviews.
The final taxonomy and labelling of terms will be 
reviewed by the advisory group and all three public 
involvement groups. Particular attention will be given to 
the language used to describe outcome areas, domains 
and specific indicators to ensure they are understandable, 
meaningful and acceptable to all stakeholder groups. 
Further refinement (including addition of areas, domains 
or indicators) will be undertaken following this review. 
The final step in the process will be to examine outcomes 
against a priori criteria designed to ensure the final COS 
has maximum utility. These include: (1) the extent to 
which the outcome indicator relates to children’s feelings, 
function or survival or the process of delivering services 
to survivors, (2) whether the outcome is ‘changeable’ 
and (3) whether the outcome indicator could feasibly 
change as a result of a psychosocial intervention–here, 
we will draw on the literature elucidating mechanisms 
through which exposure to violence and abuse may be 
communicated to child outcomes (eg, Cameranesi and 
Piotrowski).45 Four members of the research team, at 
least two members of the expert advisory group and four 
members of the survivor involvement groups (with equal 
representation of CM and DVA experience) will inde-
pendently assess outcome indicators against the criteria 
listed above. Any indicators identified as not meeting all 
criteria will be discussed and a decision taken to exclude 
or include it in the candidate list. Excluded outcomes 
will be reported in the final paper, along with reasons for 
exclusion. Where needed, a glossary of terms and explan-
atory text will be developed to aid clarity for participants 
in the E- Delphi Study.
Phase II
Adapted international E-Delphi Study
A sequential two- round, three- panel E- Delphi Study will 
be conducted.
Round 1: A questionnaire for use in the E- Delphi Study 
will be developed using the taxonomy described above. 
Areas and domains will serve as headings and subhead-
ings by which to organise the survey, so as to encourage 
completion and to allow us to explore the relative impor-
tance of indicators within the same domain. The ques-
tionnaire will be reviewed by advisory and involvement 
groups and refined in line with feedback. Ethical approval 
will be sought as an amendment to that granted for phase 
I of the study.
Participants will be contacted by email to remind them 
about the COS study and their attendance at a previous 
workshop (if appropriate) and to invite them to partic-
ipate in the E- Delphi Study. A second email containing 
the information sheet and link to an online questionnaire 
will be sent 1–2 days after the initial contact. Participants 
will be required to indicate that they have read the infor-
mation sheet and agree to take part, before proceeding 
to the questionnaire. The questionnaire will be admin-
istered via Qualtrics (https://www. qualtrics. com/ uk/) 
hosted by the University College London.
Participants will be presented with a list of outcome 
indicators organised by area and outcome domain. They 
will be asked to rate each outcome presented, on a 9- point 
scale of importance (1=not at all important, 9=extremely 
important). Participants will also be given the opportu-
nity to add any additional outcomes that are missing from 
each domain using a free- text comments box. During this 
round, we will also collect demographic data including 
ethnicity, age, gender, profession and country of profes-
sional operation. The questionnaire will remain open for 
14 days and reminder emails will be sent out at 7 and 2 
working days before closure.
Item- level descriptive statistics will be generated for 
each panel and item including: number of respondents, 
minimum and maximum values, measures of central 
tendency and dispersion. Criteria for item inclusion in 
round two will be an item is rated 7–9 (on a 9- point Likert 
Scale) by 50% or more participants in at least one panel 
and 1–3 by no more than 15% of participants in any stake-
holder group.46 This low threshold for inclusion enables 
us to reduce response burden in round two by dropping 
unimportant items given higher number of items are 
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associated with significantly lower response rates in COS 
Delphi surveys,47 while also reducing the likelihood of 
dropping outcomes that may have been rated more highly 
in subsequent rounds had participants been given feed-
back on them. New items will be included if two or more 
panellists suggest inclusion and the research team deem 
it unique to existing content.15 Panellists completing 
round one will be invited to participate in round two if 
they rated ≥50% of survey items. Non- completers will 
not be contacted for participation in round two. We will 
assess attrition rates for each panel and by demographic 
profiles.
Round two: An amendment to the existing approval will 
be sought for use of the shorter round two questionnaire. 
The same items will be included in questionnaires issued 
to each panel. Each panel member will receive a person-
alised questionnaire reporting panel averages and their 
own rating for each item. As noted above, professional 
and researcher panels will also receive feedback about the 
ratings of the survivor panel. Panellists will be asked to 
re- rate each of the included items and rate for the first 
time any new outcomes put forward in round one. All 
new outcomes suggested in round one (irrespective of 
the panel from which they derived) will be presented to 
each of the three panels.
As before, participants will receive two reminders to 
complete the questionnaire, over the course of 14 days. 
Following completion of the study, descriptive statistics 
will be computed. Items will be deemed important to a 
particular panel if they are rated 7–9 by ≥70% of respon-
dents and 1–3 ≤15% by the panel. Conversely, items will 
be classified as unimportant to a group if ≥70% of respon-
dents rate it as 1–3 and ≤15% rate it as 7–9. Any items not 
classified as important or unimportant will be deemed 
not to have reached consensus. Items will be considered 
‘core’ and recommended for inclusion in the COS if they 
are rated as important by all three panels. We will assess 
the impact of attrition on consensus by comparing (within 
panels) the mean total item scores for those completing 
round one only and those completing both rounds; we 
will also compare the average scores for completers versus 
non- completers by each item (within panel).15
Consensus meeting
A face- to- face consensus meeting, with a purposively 
sampled panel (n=30) representing all key stakeholder 
groups, will be held to discuss, vote and agree on the 
final CM- COS and DVA- COS. The format of the meeting 
will follow the process set out by the James Lind Alliance 
(JLA) final priority setting workshops http://www. jla. 
nihr. ac. uk/ jla- guidebook/ chapter- 8/ workshop- process- 
on- the- day. htm. This method is pertinent given that JLA 
priority setting meetings involve multiple stakeholders, 
discussion of interim results derived from the ranking of 
evidence uncertainties and production of a ‘top ten’.
While there is no recommended maximum number 
of outcomes that should be included in a COS, for it 
to be pragmatic we aim to arrive at a maximum of 10 
outcomes.48 49 The JLA priority setting method involves a 
structured process including small group and whole group 
discussion, ranking and reranking. The method will be 
adapted to include a preliminary step, where participants 
review those outcomes identified as important to the lived 
experience panel, but which did not reach consensus 
across all groups. Participants will be asked to identify 
any outcomes that should be discussed in the workshop, 
alongside outcomes meeting the consensus definition. 
This initial step is an attempt to ensure appropriate 
weight is given to the voice of those with lived experience 
of DVA/CM. During discussion, workshop participants 
will be asked to take into consideration the extent to 
which identified outcomes are ‘changeable’, and could 
be feasibly impacted by psychosocial interventions. The 




Ethical approval was sought from the Research Ethics 
Committee at University College London. At all stages of 
the study, we will obtain written consent for contact infor-
mation relating to potential participants to be passed via 
gatekeeper organisations assisting with recruitment. We 
will obtain written informed consent from participants 
in interviews and the consensus meeting. Online consent 
will be obtained from participants when they opt in to 
participate in the E- Delphi Study, before they are able to 
proceed.
Dissemination and implementation
We have registered the study on the COMET website. 
We will provide tailored briefings to UK policy- makers, 
think tanks, commissioners and third sector organisations 
while the study is in progress as well as completed. This 
will maximise interest and intention to use the COSs. We 
also intend to use these briefings as a vehicle for recruit-
ment to the E- Delphi Study. We will involve the leads of 
international scholarly networks in workshops and recruit 
member networks to the E- Delphi Study.
We will disseminate our findings through peer- reviewed 
and open access publications, the COMET website and 
presentations at international conferences. We will 
engage with journal editors and funding agencies and 
the relevant Cochrane and Campbell review groups to 
promote awareness of the CM- COS and DVA- COS. We 
will provide briefings and links to publications to inter-
national research and policy networks, for dissemination 
through the Violence, Abuse and Mental Health Network 
(VAMHN) membership and NIHR Children and Families 
Policy Research Unit (CPRU) collaborators, as well as the 
wider network of National Institute for Health Research 
(NIHR) Policy Research Units, Applied Research Collab-
orations and UK Research and Information (UKRI) 
networks. We will invite survivors who participated in 
workshops and in involvement groups to coproduce 







pen: first published as 10.1136/bm




8 Howarth E, et al. BMJ Open 2021;11:e044431. doi:10.1136/bmjopen-2020-044431
Open access 
plain- language, service- user facing communication 
materials for circulation in places where survivors access 
support (formal or informal). We will also develop tailored 
briefings to enable findings to be shared with all study 
participants; participation in this type of study is known to 
be a key facilitator of implementation.15 Briefings will be 
published on the CPRU website and emailed to all third 
sector organisations working specifically with survivors 
of CM and DVA, as well as local authority commissioners 
and Clinical Commissioning Groups (CCG).
A high- level review of the reach and uptake of the 
COSs will be undertaken in 2023. One of the key issues 
for review will be whether the COS has become aligned 
or adopted by research and practice networks or collabo-
rations and recognised by funders (eg, NIHR) and bodies 
coordinating health and social care intervention research 
and systematic reviews (eg, Cochrane and Campbell 
Collaborations).
DISCUSSION
Currently no published COS exists for evaluation of 
services and interventions to improve child outcomes 
following experience of CM or DVA. It is essential that 
outcomes measured in the context of trials and practice- 
based research reflect the benefits (and harms) sought 
and prioritised by those who use, deliver and commission 
DVA and CM programmes, as well as those who research 
them. A COS that is developed with strong participation 
from people with lived experience of CM or DVA and 
those working to support them will help to ensure that 
relevant outcomes are measured in all evaluative studies. 
This in turn will enhance consistency across studies and 
the quality and value of research. High levels of awareness 
and uptake of this study’s outputs are critical to achieve 
its ultimate aim.
Limitations
The design of this study is limited by the lack of direct 
involvement of children and young people in either qual-
itative interviews or the E- Delphi Study. Given the study 
described here represents meta- research, it was felt that 
potential risks to children could not be justified. Their 
voices are nonetheless to some extent reflected through 
the broad reviews of evidence and inclusion of parent 
perspectives. It is also beyond the means of the study to 
involve survivors and service providers from low- income 
and middle- income countries (LMICs), although we will 
include research from LMICs in the evidence reviews and 
actively recruit researchers from or researching LMIC 
settings.
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Supplementary Appendices – Rapid Review Protocols 
 
A - Rapid review of systematic reviews of intervention studies  
 
Review question: How are outcomes defined and measured in controlled trials of interventions 
aiming to improve outcomes of children and families with children exposed to DVA/CM and those 
aiming to reduce subsequent abusive behaviour by perpetrators of DVA/CM? 
a. This includes the definition and measurement of DVA/CM. 
This rapid review will be carried out in two steps: firstly searches for systematic reviews (SR) will be 
carried out, then these reviews will be used to extract individual studies which will be screened for 
relevance. This process will be carried out in parallel for the DVA and CM literature. 
 
Study inclusion: Peer-reviewed systematic reviews of controlled or quasi experimental comparator 
intervention studies: with or without randomisation.  
The DARE criteria for SRs are at least 4 of the following: reporting of inclusion/exclusion criteria; 
adequate search; synthesis of included studies; quality assessment of studies; sufficient detail 
presented (CRD, 1995). For the purposes of this review, SRs will be included if they use an electronic 
database and have a structured search strategy. 
• Published since 2014. 
• No restrictions by country. English language only. 
 
• Individual studies must include DVA/CM in one of the following ways: 
o Entry to the intervention is determined by experience, perpetration or identified as at 
risk of DVA/CM. (Identification of risk is by researchers, practitioners or participants thus 
we do not have a definition) 
o Subgroup analysis is carried out of participants who have experienced (or are considered 
to be at risk of) DVA/CM 
o DVA/CM is measured as an exposure (this could be retro or prospectively reported) 
 
Exclusion: Non peer-reviewed studies, qualitative studies, general literature reviews, protocols, case 
reports, cross-sectional studies, general discussion papers, letters, commentaries, book chapters, 
conference papers, theses and dissertations. 
 
Population inclusion: children or families with children at risk of experiencing, or experiencing 
DVA/CM’. This includes unborn children, children (aged 0 to 18 years), designated as victim or 
witness. For DVA any adult family members who have a parenting role (Early Intervention 
Foundation, 2014), whether designated as perpetrator, victim, witness or household member.  
For CM any adult family members who have a caring role, whether designated as maltreating parent, 
witness or household member. These adults and children could either be the primary study 
population of interest or form a subgroup in a wider study population.  
 
Intervention inclusion: Any interventions or services where:  
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
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• Experience of or increased risk of experiencing DVA/CM is a criterion for being offered the 
service 
OR 
• DVA/CM is measured as an exposure or outcome of interest 
AND 
• At least one child or family-level outcome is measured. Family-level outcomes do not need 
to be explicitly labelled as ‘family’ level, we will make a judgement. However, they include 
any outcome that affects the family/household unit. For example, worklessness in study 
where at least some participants are reported to be parents would be included. 
 
• Studies must include evaluation of a defined activity/programme and evaluation of a 
hypothesised effect  
• Interventions may be delivered to any family member(s) as an individual or in a group. Any 
duration of intervention will be included. Any setting will be considered. 
 
Exclusion: universal interventions that do not specifically target children and families at risk of 
DVA/CM; targeted interventions that do not measure any child or family level outcomes e.g. 
perpetrator programmes that focus solely on attitudinal change; DVA (only) interventions focused 
solely on elder abuse, sibling abuse or child perpetration of domestic violence where participants 
have not been identified as exposed to DVA. 
 
Comparator inclusion: Any control or comparison group/period with participants receiving no care, 
treatment as usual or any other treatment. 
 
Outcome inclusion:  
• Any child outcome related to i) the child’s experience of adversity ii) child functioning, 
including risky behaviours (see (Maclean et al., 2016) for full list of health and wellbeing 
outcomes). 
• Any outcomes related to the quality of the caregiving environment (e.g. parenting, maternal 
depression, stressful life events, maternal psychological distress, parental substance misuse). 
• Any outcomes related to material deprivation e.g. low income, economic hardship or stress 
(including perceived), social capital, hunger, food poverty, housing instability. 
• Any other outcome judged to relate to children or families by the research team.  
• Outcomes can be reported by professionals, child, parent or other family member and they 
can be retrospective or prospective. 
• Outcomes can be end points, surrogate markers for end points or intermediate outcomes. 
• No minimum or maximum follow-up is required. 
 
Context inclusion: Studies from any country in any setting.  
 
Searches 
The following electronic databases will be searched from 2014: Medline, Embase, PsycInfo, 
Cochrane and Web of Science. Searching will include expert recommendations of relevant broader 
studies, including relevant parenting programmes. 
 
The search strategy will include MeSH terms relating to DVA/CM and the BMJ systematic review 
strategy ((Study Design Search Filters | BMJ Best Practice, n.d.)). Key word terms for DVA/CM, abuse, 
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violence, family members and systematic reviews will be used. These have been developed from the 
two main NIHR-funded studies in the area ((Howarth et al., 2016) and (Macdonald et al., 2016)) and  
adapted as required for the different databases with guidance from an expert librarian.  
 
These reviews will be carried out separately for DVA and CM. The DVA search will be run first and 
any CM studies that do not mention DVA will be excluded (and vice versa). As part of the review 
involves collecting definitions of DVA/CM, any study deemed to fit within the umbrella by the 
research team will be included. 
 
Data extraction (selection and coding) 
All systematic reviews identified by database searches will be downloaded to CADIMA (Kohl et al., 
2018) and de-duplicated. Screening criteria will be tested by two reviewers on 200 titles/abstracts 
and interrater reliability assessed. Titles/abstracts will be screened by one reviewer for inclusion in 
full-text review. A second reviewer will independently review 10% of title/abstracts. If there is a high 
level of disagreement, the second reviewer will continue reviewing titles/abstracts until agreement 
is reached. Full-text systematic reviews will be screened for inclusion and a second reviewer will 
independently review 10% of these as above. Key data from the systematic reviews (e.g. definition 
of DVA/CM) will be extracted into CADIMA by one reviewer.  
 
Individual studies will be extracted from the included full-text systematic reviews. These studies will 
be downloaded to Zotero and de-duplicated. The remaining studies will then be screened for 
inclusion in full-text review and data extraction. Data will be extracted into Access using a 
standardised form and a second researcher will review extraction from the first 5 papers. The 
following data will be extracted: bibliographic information, study design, setting, sample 
characteristics, definitions of DVA/CM, intervention details, primary and secondary outcomes 
(applicable for children and families) and their measures, descriptions of mechanisms. (Where 
DVA/CM is not measured as an outcome, nor is there a subgroup analysis, only exposure definition 
will be extracted.) Quality control/risk of bias will not be assessed because the aim of the review is 
solely to collect outcomes. 
 
Strategy for data synthesis 
Narrative synthesis and tabulation of outcomes extracted. 
 
 
B - Rapid review of qualitative studies  
 
Review questions:  
1) What outcomes (benefits or harms) are sought or experienced by actual or potential recipients of 
interventions/services aiming to prevent or reduce the risk of harm associated with DVA/CM? 
2) What outcomes (benefits or harms) are sought by stakeholders* involved in developing and/or 
delivering interventions to children/families experiencing DVA/CM? 
*’stakeholder’ is defined as in the IMPROVE study i.e. young people with experience of DVA/CM 
services, parents/caregivers with experience of using DVA/CM services or professionals involved in 
commissioning and delivering services to families affected by DVA/CM. 
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This review will be carried out in parallel for DVA and CM. 
 
Study inclusion:  
• Primary qualitative (i.e. analysis of interviews, focus groups or other verbal analysis which is not 
quantified) intervention studies either as a standalone study or a discrete component of mixed-
method studies.  
• Direct and sufficient verbatim text from participants for analysis (i.e. more than two lines) c.f. 
Arai et al. (2019). 
• Published since October 2015 (DVA) and July 2014 (CM) to build on Howarth et al. (2016) and 
Macdonald et al. (2016). 
• No restrictions by country. English language only. 
 
• Individual studies must include DVA/CM in one of the following ways: 
o Participation in the study is determined by experience, perpetration or specifically 
identified as at risk of DVA/CM. Participants may have received an intervention or may 
be discussing the impact of DVA/CM and their desired outcomes for the future. (To 
ensure we are not limited by outcomes defined by current interventions). 
OR 
o Stakeholders involved in developing and/or delivering interventions to children/families 
experiencing DVA/CM (c.f. Howarth et al, 2016, p.52), or stakeholder discussion of 
outcomes that are sought either in relation to an intervention or the future in general. 
 
Exclusion: Non peer-reviewed studies, surveys or quantitative studies with descriptive free-text only, 
general literature reviews, case reports, general discussion papers, letters, commentaries, editorials, 
book chapters, conference papers, theses and dissertations. 
 
Population inclusion: Any adult or child stakeholders relevant to DVA/CM. This could be as a result 
of experience, perpetration, identified as at risk, delivering, commissioning or intending to deliver 
services. 
 
Phenomenon of interest: DVA/CM 
 
Design: Any qualitative approach to data collection and analysis (e.g. interviews, focus groups) 
 
Evaluation: Perspectives of experienced or anticipated benefits or harms of interventions, and/or 
desired outcomes in general related to DVA/CM. 
 
Searches 
The following electronic databases as advised for qualitative research (Evans, 2002; McFadden et al, 
2012; Booth, 2016) will be searched from October 2015 (DVA) and July 2014 (CM): ASSIA, CINAHL, 
GoogleScholar (first 100 hits), PsycInfo and SSCI. 
 
This review is building on Howarth et al. (2016) and Macdonald et al. (2016) so relevant studies from 
these reviews (and related work such as Arai et al. (2019)) will be included. In addition, expert 
recommendations of relevant qualitative studies or reviews and any qualitative studies identified 
from the reviews of systematic reviews will be included. 
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The search strategy will use the same terms for DVA/CM as the review of systematic reviews, plus 
additional search terms to identify qualitative research. These will be adapted as required for the 
different databases with guidance from an expert librarian. 
These reviews will be carried out separately for DVA and CM. The DVA search will be run first and 
any CM studies that do not mention DVA will be excluded (and vice versa) but put aside for inclusion 
in the relevant review. This review will not adhere to set definitions of DVA/CM, thus any study 
deemed by the research team to address the phenomena of interest will be included and justified in 
the discussion of findings. 
 
Screening 
Screening of abstracts from the searches and articles included in the full text stage will be guided by 
questions asked in the IMPROVE study (Howarth et al., 2016): 
1) Is this qualitative research?  
2) Is there sufficient verbatim text? (i.e. more than 2 lines) 
3) Does the paper discuss perspectives of experienced or anticipated benefits or harms of 
interventions, and/or desired outcomes in general related to DVA/CM. 
 
All articles identified by searches will be downloaded to CADIMA (Kohl et al., 2018) and de-
duplicated. Screening criteria will be tested by two reviewers on 10% titles/abstracts and interrater 
reliability assessed. Titles/abstracts will be screened by one reviewer for inclusion in full-text review. 
A second reviewer will independently review 10% of title/abstracts. If there is a high level of 
disagreement, the second reviewer will continue reviewing titles/abstracts until agreement is 
reached. Full-text systematic reviews will be screened for inclusion and a second reviewer will 
independently review 10% of these as above. Key details (e.g. bibliographic information, study 
design, setting, participants etc.) about each full-text inclusion will be recorded in Access. 
 
Strategy for data synthesis 
Thematic frameworks will be developed from the IMPROVE study (Howarth et al., 2016) for DVA and 
the parallel CM study (MacDonald et al., 2016), and input into NVivo 11 (QSR International). The 
frameworks will focus on barriers and harms of interventions according to parents, children and 
stakeholders, based on the research questions. These will be used as the basis for a framework 
analysis (Ritchie & Lewis, 2003) of the studies from the review (Howarth et al., 2016; Arai et al., 
2019; Macdonald et al., 2016). As per Howarth et al. (2016), participant quotations and author-
identified themes will be extracted rather than line by line coding. Findings will be grouped by whose 
view was reported and extracts from the texts will be categorised according to this framework with 
the aim will be to meta-aggregate the studies’ findings.  Further categories will be developed where 
there are discrepancies or gaps in the initial framework.  
 
The analysis and interpretation of the findings will occur at the synthesis stage in order to provide an 
overview of the findings, informed by the principles of meta-synthesis (c.f. Noblit & Hare, 1988), 
although using a lighter touch given time constraints. Two researchers will work together 
throughout this process to ensure consistency of categorisation and analysis. Quality will not be 
assessed because the aim of the review is solely to identify candidate outcomes. The ENTREQ 
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C – Rapid review of grey literature 
 
Review questions: 
1) How are DVA and CM defined in relevant UK service policy contexts? 
2) How are outcomes defined: (i) in UK service-based evaluations of interventions? (ii) in 
relevant policy or commissioning frameworks? 
This review will be carried out as a single process given the likelihood of crossover literature. 
Findings will be recorded as DVA or CM or both. 
 
Literature inclusion:  
• Any national or regional policy or practice document that reports on DVA/CM-relevant 
services or outcomes (e.g. measurement/theory). 
• Participation in the service is determined by experience, perpetration or identified as at risk 
of DVA/CM. (Identification of risk is by practitioners or participants thus we do not have a 
definition). 
• Published since 2016 to build on Howarth et al. (2016) and Macdonald et al. (2016). 
• England-based only. English language only. 
Exclusion: Publication in academic journals, book chapters, conference papers, theses and 
dissertations. 
Population inclusion: children or families with children at risk of experiencing, or experiencing 
DVA/CM. This includes unborn children, children (aged 0 to 18 years), designated as victim or 
witness. For DVA any adult family members who have a caring or parenting role (Early Intervention 
Foundation, 2014), whether designated as perpetrator, victim, witness or household member. For 
CM any adult family members who have a caring role, whether designated as perpetrator, witness or 
household member. 
 
Service inclusion: Any services where:  
• Experience of or increased risk of experiencing DVA/CM is a criterion for being offered the 
service/intervention. 
• Services/interventions may be delivered to any family member(s) as an individual or in a 
group. Any duration of service/intervention will be included. Any setting will be considered. 
OR 
• Any evaluative work or outcomes framework where at least one child or family-level 
outcome is evaluated/discussed. Family-level outcomes do not need to be explicitly labelled 
as ‘family’ level, we will make a judgement. However, they include any outcome that affects 
the family/household unit. For example, worklessness in study where at least some 
participants are reported to be parents would be included. 
 
Exclusion: universal services/interventions that do not specifically target children and families at risk 
of DVA/CM; targeted services/interventions that do not measure any child or family level outcomes 
e.g. perpetrator programmes that focus solely on attitudinal change; DVA (only) 
services/interventions focused solely on elder abuse, sibling abuse or child perpetration of domestic 
violence, where participants have not been identified as exposed to DVA (i.e. perpetration of abuse 
by a child could feasibly be an outcome associated with exposure). 
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Outcome inclusion: Any family or child-level outcome measured or evaluated or discussed in any 
way. Intermediate outcomes that could feasibly represent preconditions needed to reach distal/final 




The following databases and websites will be searched: 
Grey databases: NICE Evidence Search and Open Grey 
Organisation websites including but not limited to: 
DVA: Women’s Aid, Refuge, Respect, Safe Lives, Voices, AVA, Standing Together, Imkaan, The 
Stefanou Foundation, Women’s Trust, Hestia, DVIP, Nia, The Haven, ManKind Initiative, Everyman 
Project, NCDV, Galop, LAWA, IDAS, Advance, Your Sanctuary, Advocacy After Fatal Domestic Abuse 
(AAFDA); Aurora New Dawn; My Sister’s Place 
CM: Centre of expertise on child sexual abuse, FDAC, SCIE, The Survivors’ Trust 
General websites: Victim Support, Barnardos, NSPCC, Early Intervention Foundation, NatCen, RCGP, 
RCN, RCM, NICE, BPS, IHV, WHO, UNICEF, Working together, gov.uk (incls e.g. DA bill, ‘Working 
together’), Public Health for any UK nation, Office of the children’s commissioner for any UK nation, 
Big Lottery, Comic Relief, The Childhood Trust, UK College of Policing, Research in Practice, ‘What 
Works’, Joseph Rowntree Foundation, What Works for Children’s Social Care. 
Websites will be searched manually for relevant documents. It is anticipated there will be an 
element of snowball searching as relevant organisations will have links to further organisations. 
Searches will be run simultaneously and then relevant reports assigned to DVA/CM or both. All 
websites searched will be recorded in Excel/Access along with relevant details about any reports 
captured. The expert reference group will be consulted about relevant websites to search or reports 
to include at multiple timepoints. 
Data extraction and synthesis 
As a range of types of data are anticipated, both the systematic review and the qualitative review 
protocols will be adapted as necessary to capture and record relevant information. It is likely that 
there will be non-standardised evaluation measures and interview quotations. Report identification 
from websites/databases will be carried out by a single researcher and the process transparently 
recorded. All details regarding evaluation studies and relevant outcomes will be recorded, and 
where necessary synthesised when the data is qualitative. Access/Excel/NVivo will be used as 
required to record all steps and ensure a transparent process. A second researcher will cross-check a 
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